Support our call for opt-out testing of hepatitis B and hepatitis C in more emergency departments

January 19, 2023

The British Liver Trust has joined with other charities leading in the fight against Hepatitis B, Hepatitis C and HIV to call on the government to fund testing for blood-borne viruses in emergency departments across England.

In an open letter launched today, we’re asking that the Government’s successful opt-out testing programme is extended to all areas with a high prevalence of HIV – from Birmingham to Portsmouth, and Derby to Peterborough.

Routinely testing patients attending A & E has already identified more than 1,000 patients with viral hepatitis and HIV in London, Manchester, Brighton and Blackpool. This now needs to be rolled out to the rest of the UK.

Opt-out testing for these viruses will help the government meet its goal of eliminating Hepatitis C in England by 2025 and HIV transmissions by 2030. There are also approximately 440,000 people living with Hepatitis B in the UK but many remain unaware they have it. This testing will help reach more people in the community and find people who may avoid testing in other settings for fear of being stigmatised.

Early diagnosis not only saves and improves the lives of people living with these viruses but saves the NHS money. This is why we’re backing an open letter to the Public Health Minister and NHS England to extend opt-out testing to 40+ new hospitals in 32 areas.

Support this call by adding your name to the letter today.

More news

Our Budget Case to the Treasury: Investing in Prevention

Our Budget Case to the Treasury: Investing in Prevention

The Autumn Budget on 28th October is a chance to prevent thousands of families from experiencing the devastating impact of liver disease. Because 90% of liver disease is preventable, government action on alcohol harm and obesity could ...
Liver UK helps shape new European recommendations on liver cancer surveillance

Liver UK helps shape new European recommendations on liver cancer surveillance

A major new paper published in The Lancet Regional Health – Europe has highlighted the challenges of detecting liver cancer earlier across Europe and sets out practical lessons from countries around the world to improve surveillance ...
The LIVERAGE research studies

The LIVERAGE research studies

The LIVERAGE and LIVERAGE Cirrhosis studies are large clinical research studies for adults living with MASLD, a type of fatty liver disease. These studies focus on people with MASH, a more advanced form of MASLD.  The studies include ...
No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.